FindTrial
Sign In

Frailty Assessment Based on Biosignal Monitoring Using Wearable Device in Older Patients with Cardiovascular Disease

Frailty Assessment Based on Biosignal Monitoring Using Wearable Device in Heart Disease Patients Over 70 Years of age Scheduled for Cardiovascular Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005107
Enrollment
100
Registered
2020-06-11
Start date
2020-06-30
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adult men and women over 70 age 2) Patients who voluntarily participated through written consent byself. 3) Patients diagnosed with cardiovascular and severe valve disease and undergoing cardiac surgical treatment.

Exclusion criteria

Exclusion criteria: 1) When walking is impossible due to physical defects 2) If life expectancy is less than 1 year due to disease 3) When hemodynamically unstable, such as severe pulmonary arterial hypertension and decrease left ventricular ejection fraction rate before surgery 4) Clinically significant patients with ischemic heart disease

Design outcomes

Primary

MeasureTime frame
Correlation coefficient of 0.6 or higher between SPPB measured by laboratory index and steps measured by wearable device—

Secondary

MeasureTime frame
Correlation coefficient of 0.6 or higher between SPPB measured by laboratory index and gait speed measured by wearable device;The correlation coefficient between biomarker and clinical index incidence measured by a wearable device is 0.6 or more—

Countries

Korea, Republic of

Contacts

Public ContactJin-Hee Won

Asan Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026